VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
VTRSViatris Inc.
$15.37$17.9B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. VTRS
  3. Financial Ratios

Viatris Inc. (VTRS) Financial Ratios

23 years of historical data (2003–2025) · Healthcare · Drug Manufacturers - Specialty & Generic

View Quarterly Ratios →

P/E Ratio
↑
-5.12
↓-104% vs avg
5yr avg: 122.79
00%ile100
30Y Low6.5·High61.4
View P/E History →
EV/EBITDA
↑
231.16
↑+380% vs avg
5yr avg: 48.12
0100%ile100
30Y Low6.9·High18.2
P/FCF
↑
9.24
↑+42% vs avg
5yr avg: 6.52
032%ile100
30Y Low5.4·High63.3
P/B Ratio
↑
1.22
↑+58% vs avg
5yr avg: 0.77
045%ile100
30Y Low0.5·High7.0
ROE
↓
-21.1%
↑-430% vs avg
5yr avg: -4.0%
09%ile100
30Y Low-72%·High30%
Debt/EBITDA
↑
108.74
↑+324% vs avg
5yr avg: 25.67
0100%ile100
30Y Low0.0·High13.0

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

VTRS Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

Viatris Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 9.2x P/FCF, 42% above the 5-year average of 6.5x.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$17.9B$14.6B$14.9B$13.1B$13.5B$16.4B$11.3B$10.4B$14.1B$22.7B$19.9B
Enterprise Value$31.3B$27.9B$28.4B$30.5B$31.8B$39.0B$36.6B$22.8B$27.5B$37.1B$34.3B
P/E Ratio →-5.12——239.076.51——670.0040.1032.5541.47
P/S Ratio1.251.021.010.850.830.910.940.901.231.911.79
P/B Ratio1.220.990.800.640.640.800.490.871.161.711.79
P/FCF9.247.527.525.625.406.5220.467.436.7412.6911.99
P/OCF7.736.296.454.674.525.429.155.766.0111.009.70

P/E links to full P/E history page with 30-year chart

VTRS EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

Viatris Inc.'s enterprise value stands at 231.2x EBITDA, 380% above its 5-year average of 48.1x. The Healthcare sector median is 14.2x, placing the stock at a 1526% premium on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—1.951.931.971.962.183.061.992.413.113.10
EV / EBITDA231.16206.579.798.686.858.7218.248.359.1211.4315.45
EV / EBIT———39.249.34——33.9932.7325.7959.55
EV / FCF—14.4214.3813.1012.6815.5666.4416.3313.1720.7320.72

VTRS Profitability

Margins and return-on-capital ratios measuring operating efficiency

Viatris Inc. earns an operating margin of -18.6%. Operating margins have compressed from 5.0% to -18.6% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -21.1% indicates the company is currently destroying shareholder equity.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin35.1%35.1%38.2%41.7%40.0%31.2%31.8%33.9%35.0%40.2%42.4%
Operating Margin-18.6%-18.6%0.1%5.0%9.9%-0.2%-1.8%6.2%7.9%12.1%6.3%
Net Profit Margin-24.6%-24.6%-4.3%0.4%12.8%-7.1%-5.6%0.1%3.1%5.8%4.3%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-21.1%-21.1%-3.2%0.3%10.0%-5.8%-3.8%0.1%2.8%5.7%4.6%
ROA-8.9%-8.9%-1.4%0.1%4.0%-2.2%-1.4%0.1%1.0%2.0%1.7%
ROIC-6.6%-6.6%0.0%1.5%2.9%-0.1%-0.4%2.1%2.5%4.0%2.5%
ROCE-8.1%-8.1%0.0%1.8%3.7%-0.1%-0.5%2.7%3.1%4.9%2.9%

VTRS Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

Viatris Inc. carries a Debt/EBITDA ratio of 108.7x, which is highly leveraged (3282% above the sector average of 3.2x). Net debt stands at $13.4B ($14.7B total debt minus $1.3B cash).

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity1.001.000.770.900.931.141.141.091.141.101.39
Debt / EBITDA108.74108.744.935.244.215.2213.054.734.584.526.96
Net Debt / Equity—0.910.730.850.871.111.101.051.101.081.30
Net Debt / EBITDA98.7798.774.674.963.935.0712.624.554.454.436.51
Debt / FCF—6.896.867.477.289.0445.988.916.438.038.74
Interest Coverage-6.78-6.78-0.131.355.75-0.04-0.451.301.552.691.27

VTRS Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

A current ratio of 1.30x means Viatris Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.74x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.67x to 1.30x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.301.301.651.671.581.101.221.211.391.131.49
Quick Ratio0.740.740.981.221.050.700.700.730.830.731.01
Cash Ratio0.210.210.190.150.220.090.100.100.100.060.21
Asset Turnover—0.380.360.320.330.330.190.370.350.330.32
Inventory Turnover2.322.322.372.592.773.091.492.852.882.802.60
Days Sales Outstanding—85.4387.2295.6092.9887.06148.0097.0877.1497.2699.36

VTRS Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Viatris Inc. returns 5.9% to shareholders annually — split between a 3.1% dividend yield and 2.8% buyback yield.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield3.1%3.9%3.9%4.4%4.3%2.4%—————
Payout Ratio———1052.3%28.0%——————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield———0.4%15.4%——0.1%2.5%3.1%2.4%
FCF Yield10.8%13.3%13.3%17.8%18.5%15.3%4.9%13.5%14.8%7.9%8.3%
Buyback Yield2.8%3.4%1.7%1.9%0.0%0.1%0.0%0.0%3.1%2.2%0.1%
Total Shareholder Yield5.9%7.3%5.6%6.3%4.3%2.5%0.0%0.0%3.1%2.2%0.1%
Shares Outstanding—$1.2B$1.2B$1.2B$1.2B$1.2B$601M$517M$517M$537M$521M

Peer Comparison

Compare VTRS with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
VTRS logoVTRSYou$18B-5.1231.29.235.1%-18.6%-21.1%-6.6%108.7
TEVA logoTEVA$37B26.216.031.951.8%12.5%20.7%7.7%5.5
AMRX logoAMRX$5B73.7—18.936.9%-0.2%15.7%-0.2%—
PRGO logoPRGO$1B-1.07.19.835.1%8.1%-39.3%3.7%5.8
PFE logoPFE$143B18.510.315.870.3%24.7%8.9%7.5%3.3
MRK logoMRK$281B15.610.822.872.0%36.2%36.9%22.0%1.7
ABBV logoABBV$383B91.415.821.570.2%32.8%6214.7%23.9%2.4
LPTX logoLPTX$65M11.0————5.1%-43.0%—
MCK logoMCK$90B19.613.215.83.6%1.6%—254.1%1.2
CAH logoCAH$52B34.418.828.23.7%1.0%—3378.7%3.0
CVS logoCVS$125B70.714.016.113.8%2.6%2.3%5.0%6.2
Healthcare Median—22.114.218.563.9%-4.3%-32.6%-11.6%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 22 years · Updated daily

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into VTRS consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

VTRS — Frequently Asked Questions

Quick answers to the most common questions about buying VTRS stock.

What is Viatris Inc.'s P/E ratio?

Viatris Inc.'s current P/E ratio is -5.1x. The historical average is 28.9x.

What is Viatris Inc.'s EV/EBITDA?

Viatris Inc.'s current EV/EBITDA is 231.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.9x.

What is Viatris Inc.'s ROE?

Viatris Inc.'s return on equity (ROE) is -21.1%. The historical average is 3.2%.

Is VTRS stock overvalued?

Based on historical data, Viatris Inc. is trading at a P/E of -5.1x. Compare with industry peers and growth rates for a complete picture.

What is Viatris Inc.'s dividend yield?

Viatris Inc.'s current dividend yield is 3.12%.

What are Viatris Inc.'s profit margins?

Viatris Inc. has 35.1% gross margin and -18.6% operating margin.

How much debt does Viatris Inc. have?

Viatris Inc.'s Debt/EBITDA ratio is 108.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.